Resolys Bio resolysbio.com


Public lists: Pharma Startups (4732)

Resolys Bio is a privately held, discovery and early-stage development biotechnology company of therapeutic agents for acute and chronic disorders. BTL has several products in pre-clinical and clinical development at any one time, with streptolysin O (SLO) emerging as one of the most attractive. Having been assigned all rights to SLO, Resolys is moving toward formal evaluation of this molecule for treatment of traumatic brain injury (TBI) with other indications to follow.

Resolys Bio is a privately held, discovery and early-stage development biotechnology company of therapeutic agents for acute and chronic disorders. BTL has several products in pre-clinical and clinical development at any one time, with streptolysin O...Show all

Company (Alive / Active)

Phone: 518-872-1144

Fax:

545 Westfall Road

Delanson, 12053
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Resolys Bio $0.2M Sep 25, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Resolys Bio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)